ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994

NCI Hires Harold Freeman To Direct New Center For Study Of Health Disparities.

June 16, 2000

NCI Expects Improved Communications to Result from Consolidation of Offices

May 12, 2000

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976